linking the diagnosis-to-treatment interval with ctdna
Published 3 years ago • 155 plays • Length 2:33Download video MP4
Download video MP3
Similar videos
-
1:41
using cytogenetics to improve the diagnosis and prognosis of mds & to predict response to treatment
-
1:51
treatment schedule for ruxolitinib in patients with mpns and how to assess response
-
2:33
what can artificial intelligence bring to the diagnosis and management of mds?
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:16
determining when to switch from hydroxyurea to interferon-based therapy in patients with pv
-
3:05
the clinical use of circulating tumor dna in t-cell lymphomas
-
4:31
labmt: impact of treatment prior to allogenic hct in mds
-
6:40
from clot to capture: linncing clot composition and clinical outcomes
-
13:42
w hematologii jesteśmy w przełomowym momencie
-
12:57
ematologia, robin foà: “oggi possiamo curare i pazienti senza chemioterapia”
-
1:37
the role of ctdna in hodgkin lymphoma
-
2:20
ebmt diagnostic criteria for tma post-allosct and the role of complement activation
-
2:21
practical considerations for dli after haploidentical sct
-
2:21
the potential applications for immunotherapy in mpns
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
2:16
correcting the function of mutated hemoglobin with gene therapy for scd
-
3:43
mrd-guided treatment cessation in multiple myeloma
-
0:45
the emerging role of ctdna in cancer diagnostics
-
1:04
clad-ldac-ven induction therapy in aml: insights from a phase ii trial
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
1:47
shared treatment decision-making